Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testosterone level and endothelial dysfunction in patients with vasculogenic erectile dysfunction.

Y A Omar1, S E Younis2, I Y Ismail1

  • 1Department of Urology, Suez Canal University, Ismailia, Egypt.

Andrology
|April 15, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reliability of prostate imaging reporting and data system version 2.1 for excluding clinically significant prostate cancer using a 1.5 tesla scanner.

BMC urology·2023
Same author

Improving bone health in prostate cancer patients starting androgen deprivation therapy: does Fracture Risk Assessment Tool (FRAX®) enhance stratification and targeted management?

Archives of osteoporosis·2022
Same author

Early administration of phosphodiesterase 5 inhibitors after induction of diabetes in a rat model may prevent erectile dysfunction.

Andrology·2019
Same author

Association between leukocytospermia and semen interleukin-6 and tumor necrosis factor-alpha in infertile men.

Andrology·2018
Same author

Assessment of seminal mast cells in infertile men with varicocele after surgical repair.

Andrologia·2016
Same author

What is the current role of intracavernosal injection in management of erectile dysfunction?

International journal of impotence research·2016

Late onset hypogonadism (LOH) is associated with higher endothelial progenitor cells (EPCs) and endothelial microparticles (EMPs) in men with vasculogenic erectile dysfunction (ED). This finding highlights a link between LOH and endothelial dysfunction in ED patients.

Area of Science:

  • Endocrinology
  • Urology
  • Cardiovascular Science

Background:

  • Endothelial dysfunction is implicated in vasculogenic erectile dysfunction (ED).
  • The relationship between late onset hypogonadism (LOH) and endothelial dysfunction in ED patients remains unclear.
  • Understanding this association is crucial for comprehensive ED management.

Purpose of the Study:

  • To investigate the association between LOH and markers of endothelial dysfunction in patients with vasculogenic ED.
  • To compare endothelial progenitor cells (EPCs) and endothelial microparticles (EMPs) levels in patients with ED and LOH versus those with ED and normal testosterone levels.

Main Methods:

  • Cross-sectional observational study of 90 men (2014-2015).
  • Groups included: vasculogenic ED with LOH (A), vasculogenic ED without LOH (B), and controls (C).
Keywords:
androgen patternendothelial dysfunctionvasculogenic erectile dysfunction

Related Experiment Videos

  • Assessed total testosterone, EPCs, and EMPs via flow cytometry.

    • Main Results:

    • Group A (ED with LOH) showed significantly lower total testosterone levels compared to groups B and C.
    • Patients with ED and LOH (Group A) exhibited significantly higher levels of EPCs and EMPs compared to controls (Group C).
    • Elevated EPCs and EMPs were observed in patients with ED and LOH (Group A) compared to those with ED and normal testosterone (Group B).

    Conclusions:

    • Late onset hypogonadism is significantly associated with increased expression of EPCs and EMPs.
    • These findings suggest a link between LOH and endothelial dysfunction in the context of vasculogenic ED.
    • Further research is warranted to explore therapeutic implications.